← Leaderboards
Elena M Gracheva
Medros, Inc.
$438,427
Attributed
$438,427
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $302.1K · FY2009–10$500K$375K$250K$125K$0
'09
'10
Funding mix
By agency
NIH$438,427 · 3
By mechanism
R43$438,427 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Safety”
- David Heimbrook · Leidos Biomedical Research, Inc.$398,099,186
- Lawrence Corey · Fred Hutchinson Cancer Center$396,952,463
- Mitchell J Malone · Texas A&M Research Foundation$329,191,208
- Gary D Acton · University Of California-Davis$320,373,312
- Melynda Holmes · Technical Resources Inc$232,659,786
- Beth Baseler · Leidos Biomedical Research, Inc.$225,257,316
Research focus
SafetyClinicPharmaceutical PreparationsPublic Health RelevanceTechnologyWhole OrganismIn SituMarketingDrug IndustryPreclinical Drug EvaluationScreening ProcedureSignal TransductionExpenditureToxic EffectGenetic ScreeningHuman DiseaseIn VitroCostDiabetes MellitusDisease ModelDrug DiscoveryDrosophila GenusAreaBiological Models
Grant awards (3)
Tunable Insulin Resistance in a Drosophila Model of Diabetes$152,114
R43 · FY2010 · DK · contact PI
Establishing Drosophila Tools for Pathway Mapping and Target Identification$150,000
R43 · FY2010 · GM · contact PI
Using Drosophila to Screen p38 Inhibitors Targeted to the Liver as Novel Diabetes$136,313
R43 · FY2009 · DK · contact PI